生命科学资讯

Other news to note for Jan. 2, 2026

Regulatory actions for Jan. 2, 2026

Money raised by biopharma

Biopharma money raised: Jan. 1-Dec. 31, 2025

BioWorld and Nasdaq stock indices

Sanofi, Corcept surprised by FDA rejections for MS, Cushing's syndrome drugs

Neuralink to kick-start 'high-volume production' of brain-computer interface devices, Elon Musk says

J&J junks $1.2B eczema therapy while Genmab clears out cancer drug

Neuro biotech Nido closes after phase 2 study fails to move needle in rare disease

AbbVie, Gilead gift themselves clinical-stage cancer drugs via licensing deals

Ex-Dividend Reminder: Match Group, OGE Energy and Agilent Technologies - Nasdaq

Holiday notice

Biohaven flunks phase 2 depression trial, adding to concerns for pivotal epilepsy readout

Ultragenyx plans major cost-cutting push after flunking phase 3 brittle bone trials

Financial Consulate Inc. Acquires New Holdings in 10x Genomics $TXG - MarketBeat

Bank Pictet & Cie Europe AG Sells 3,510 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Thermo Fisher Scientific Inc. $TMO Shares Purchased by Allspring Global Investments Holdings LLC - MarketBeat

Market Review: Why Waters Corporation stock remains on buy lists - July 2025 Snapshot & Risk Controlled Stock Alerts - moha.gov.vn

Agilent Technologies Stock: Quiet Drift, Subtle Shifts – Is This Calm Before A Bigger Move? - AD HOC NEWS

Agilent Technologies Stock: Quiet Drift, Subtle Shifts – Is This Calm Before A Bigger Move? - AD HOC NEWS